T78.2XXA

Anaphylactic shock, unspecified, initial encounter

Anaphylactic shock (T78.2XXA) represents a severe, life-threatening Type I hypersensitivity reaction characterized by a systemic release of mediators from mast cells and basophils. This clinical emergency results in profound peripheral vasodilation, increased capillary permeability, and extravascular smooth muscle contraction. The 'unspecified' designation indicates that the triggering allergen—be it food, medication, or venom—has not been identified or is not documented. As an 'initial encounter' code, it is utilized during the active phase of treatment, typically in emergency or acute care settings where the patient is receiving definitive management for the acute shock state. Pathophysiologically, the resulting distributive shock leads to critical hypotension and potential multi-organ failure if not rapidly reversed with intramuscular epinephrine and aggressive fluid resuscitation.

Clinical Symptoms

  • Severe hypotension (systolic BP < 90 mmHg or 30% drop from baseline)
  • Tachycardia (compensatory rapid heart rate)
  • Generalized urticaria (hives) and intense pruritus
  • Angioedema (swelling of lips, tongue, or periorbital tissues)
  • Laryngeal edema causing stridor or hoarseness
  • Bronchospasm resulting in wheezing and chest tightness
  • Dyspnea and rapid respiratory rate
  • Nausea, vomiting, and abdominal cramping
  • Sense of impending doom (aura of dread)
  • Syncope or loss of consciousness
  • Cyanosis (bluish skin tint due to hypoxia)
  • Incontinence (in severe cases of shock)

Common Causes

  • Idiopathic anaphylaxis (cause unknown after clinical investigation)
  • Undiagnosed food allergy (e.g., hidden nuts, shellfish, or dairy components)
  • Unidentified drug hypersensitivity (e.g., NSAIDs, antibiotics, or contrast media)
  • Insect venom from an unnoticed sting (Hymenoptera species)
  • Latex exposure in sensitized individuals
  • Physical triggers such as exercise-induced anaphylaxis
  • Previous history of atopic disease (asthma, eczema, or allergic rhinitis)
  • Mast cell activation syndromes (MCAS)

Documentation & Coding Tips

Differentiate between anaphylactic reaction and anaphylactic shock by documenting sustained hypotension or end-organ hypoperfusion.

Example: Patient presented with acute laryngeal edema and diffuse urticaria following an unknown ingestion. Blood pressure was 82/44 mmHg, signifying anaphylactic shock. Emergent treatment with 0.3 mg IM Epinephrine was administered. This initial encounter is documented for acute stabilization. No prior history of severe allergies noted. HCC mapping for shock is supported by clinical vital signs and immediate intervention requirements.

Billing Focus: The encounter must be labeled as initial (A), subsequent (D), or sequela (S) based on the phase of treatment.

Identify the specific trigger whenever possible to avoid unspecified codes which are prone to payer audits.

Example: Documentation clarifies that while the patient was eating a mixed salad, the specific allergen remains unidentified after initial assessment. Blood pressure stabilized at 110/70 after two doses of Epinephrine. Plan includes referral for skin prick testing. In the absence of a known trigger, T78.2XXA is utilized for the initial stabilization phase.

Billing Focus: Laterality does not apply here, but the specific allergen should be documented if known to transition from T78.2 to a more specific code like T78.01.

Document the presence of multisystem involvement including cutaneous, respiratory, and cardiovascular systems.

Example: Patient exhibited wheezing (respiratory), generalized hives (cutaneous), and a 40 percent drop from baseline systolic blood pressure (cardiovascular). This triad confirms the diagnosis of anaphylactic shock rather than a simple allergic reaction. Treatment included high-flow oxygen, IV fluid bolus, and antihistamines. High-complexity decision-making was required.

Billing Focus: Documentation of multisystem involvement supports the use of high-level E/M codes such as 99285 or 99291.

Always specify the encounter status for injury and poisoning codes as required by ICD-10-CM Chapter 19 guidelines.

Example: Initial encounter (A) is documented for the patient's first presentation to the Emergency Department for active treatment of acute anaphylactic shock. The patient is being actively managed with continuous monitoring and pharmacological intervention.

Billing Focus: The seventh character A is mandatory for the initial encounter where the patient is receiving active treatment.

Record all life-saving interventions and the patient's response to treatment to justify medical necessity.

Example: Following the diagnosis of anaphylactic shock of unknown etiology, the patient received 0.5 mg IM Epinephrine and a 2-liter Normal Saline bolus for refractory hypotension. Post-intervention BP improved to 102/64. Patient remains on continuous cardiac monitoring. High-level medical decision-making is documented due to the life-threatening nature of the presentation.

Billing Focus: Detailed intervention records support the use of CPT codes for injections (96372) and infusions (96360).

Relevant CPT Codes

Related Diagnoses

Hierarchy